Blog | The Burden of Non-Communicable and Chronic Diseases in Africa

March 18, 2026

NCDs Now Account for Over One-Third of Deaths in Uganda — Strengthening Access Systems Is No Longer Optional

Sub-Saharan Africa is undergoing a profound epidemiological transition. Over the past two decades, countries across the region have made historic progress in expanding access to antiretroviral therapy, reducing malaria mortality, and improving maternal and child health outcomes. Yet alongside these gains, a quieter but equally consequential shift has taken place.

Non-communicable diseases (NCDs) now account for an estimated 37–40% of all deaths in Sub-Saharan Africa, and approximately 40% of Uganda’s total disease burden. Cardiovascular disease, diabetes, cancer, chronic respiratory disease, chronic kidney disease, sickle cell disease, and mental health disorders are rising steadily — often presenting earlier in life than in high-income settings. Nearly two-thirds of NCD deaths in the region occur before age 70, disproportionately affecting economically productive populations and placing sustained pressure on families and health systems

The country-level data are equally compelling. Hypertension prevalence among Ugandan adults is estimated at approximately 25%. Annual oncology incidence exceeds 34,000 new cases. Asthma affects nearly 30% of children and adolescents in urban settings. Over 1.2 million Ugandans remain on ART, and as this population ages, multimorbidity — including hypertension, diabetes, CKD, and depression — is becoming increasingly common.

Mental health represents a particularly urgent and often under-recognized dimension of this transition. Depression and anxiety disorders are leading contributors to years lived with disability and are closely intertwined with chronic disease outcomes. Untreated depression is strongly associated with reduced adherence to ART, insulin therapy, and antihypertensive regimens, directly undermining clinical gains across disease programs.

However, health systems across the region remain largely configured for episodic, acute care rather than continuous, lifelong management. Only 34% of health facilities have basic NCD diagnostic tools such as blood pressure machines and glucometers. Essential NCD medicines are frequently unavailable at primary care level. Out-of-pocket spending accounts for approximately 33% of NCD drug expenditures, exposing households to catastrophic financial risk. Uganda alone faces an estimated USD 32.98 billion financing gap for NCD prevention and control.

These figures reflect not simply a clinical challenge, but a structural systems gap — encompassing procurement, forecasting, distribution, financing, workforce capacity, and digital interoperability.

Non-communicable diseases require uninterrupted medicine availability, decentralized diagnostics, cold-chain management for temperature-sensitive products such as insulin, robust pharmacovigilance systems, and predictive supply chain analytics capable of supporting lifelong therapy. The transition from infectious disease dominance to chronic multimorbidity demands a parallel transition in health system design.

Medical Access was established during a similarly pivotal moment in public health history.

In 1998, at the height of the HIV epidemic, we supported the introduction of Uganda’s first large-scale antiretroviral access initiative under the UNAIDS Drug Access Initiative. At that time, annual treatment costs exceeded US$6,000 per patient, and supply systems were fragmented. Through pooled procurement, disciplined forecasting, supplier negotiation, digital inventory systems, and last-mile distribution strengthening, first-line ART costs were reduced to below US$70 per patient annually, while ensuring uninterrupted supply for more than 30% of Uganda’s HIV patients.

Over the past 27 years, Medical Access has managed more than US$60 million annually in national supply chain operations, supported health systems across 35+ countries, and delivered chronic care medicines to over 2 million patients.

Through our NCD+ Access Strategy (2025–2030), we are now applying this proven systems architecture — procurement discipline, digital traceability, warehouse optimization, cold-chain infrastructure, and data-driven forecasting — to chronic and mental health care.

Achieving Universal Health Coverage in Uganda and across Sub-Saharan Africa will depend not only on expanding clinical services, but on strengthening the underlying access architecture: ensuring availability, affordability, quality assurance, and supply continuity for essential NCD medicines and diagnostics.

Africa’s next major public health transformation will not be defined solely by defeating infectious diseases. It will be defined by building resilient, integrated, and digitally enabled systems capable of sustaining lifelong care for millions living with chronic conditions.

The epidemiological transition is already underway. Strengthening NCD access systems must follow with equal urgency.